Sleep apnea syndrome
Conditions
Interventions
Administration of Eszopiclone
Sponsors
Keio University School of Medicine, Department of Otolaryngology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) severe sleep apnea syndrome (AHI->20) 2) being treated by CPAP 3) CPAP intolerance
Exclusion criteria
Exclusion criteria: 1) patients who are prohibited to take Eszpiclone 2) patients without informed consent 3) patients with severe hypoxemia at night 4) patients on psychiatric medication 5) patients with untreated nasal diseases such as deviation of nasal septum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| average duration of CPAP usage for 4 weeks after the start of hypnotic | — |
Countries
Japan
Contacts
Public ContactNaoki Oishi
Keio University School of Medicine Department of otolaryngology
Outcome results
None listed